A genotype-phenotype screening system using conditionally immortalized immature dendritic cells.

Liwei Zhao1,2, Peng Liu1,2, Wei Xie1,2,3

  • 1Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France.

STAR Protocols
|August 25, 2021
PubMed
Summary

This study presents a new CRISPR/Cas9 gene knockout protocol for dendritic cells (DCs). This method enables comprehensive genetic screening of DC functions and their role in anticancer immunity.

Related Concept Videos